HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons
- 10 March 2005
- journal article
- Published by Elsevier in Brain Research
- Vol. 1037 (1-2) , 52-58
- https://doi.org/10.1016/j.brainres.2004.12.051
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Effect of pitavastatin against expression of S100β protein in the gerbil hippocampus after transient cerebral ischaemiaActa Physiologica Scandinavica, 2004
- Pitavastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, reduces hippocampal damage after transient cerebral ischemia in gerbilsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
- Comparing HMG-CoA reductase inhibitorsClinical Cardiology, 2003
- Treatment of Acute Ischemic Stroke: Recent Progress.Internal Medicine, 2002
- Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.The American Journal of Cardiology, 2001
- Aggressive lipid therapy in the statin eraProgress in Cardiovascular Diseases, 1998
- Reduction of Ischemic Damage by Application of Vascular Endothelial Growth Factor in Rat Brain after Transient IschemiaJournal of Cerebral Blood Flow & Metabolism, 1998
- Role of Oxidants in Ischemic Brain DamageStroke, 1996
- Silent Cerebral Infarction in a Community-Based Autopsy Series in JapanStroke, 1995
- Serum Lipids and Nutritional Intake in a Japanese General Population: The Hisayama StudyAnnals of the New York Academy of Sciences, 1993